AI
Roche gains CE Mark for AI glucose monitoring system for diabetes management
July 9, 2024Medical Communications AI, Diabetes, Roche, diabetes, glucose monitoring
Roche has announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution.
Bayer and Aignostics to collaborate for AI oncology research
March 14, 2024Research and Development AI, Bayer, Oncology, research
Bayer and Aignostics have announced that they have entered into a strategic collaboration for several artificial intelligence (AI)-powered approaches for …
Isomorphic Labs to collaborate with Eli Lilly
January 11, 2024Research and Development AI, Eli Lilly, Isomorphic Labs, Pharmacy, drug discovery
Isomorphic Labs has announced that it has entered into a strategic research collaboration with Eli Lilly and Company, marking the …
Merck collaborates with Acceleration Consortium for AI experimentation
December 8, 2023Research and Development AI, Acceleration Consortium, Merck, Pharmacy, experimentation
Merck and the Acceleration Consortium have announced their AI-driven experimentation planner Bayesian Back End (BayBE) is now available open-source on …
Genentech and NVIDIA enter AI research collaboration
November 22, 2023Research and Development AI, Genentech, Pharmacy, research collaboration
Genentech has announced that it has entered into a multi-year strategic research collaboration with NVIDIA that is intended to pair …
Exscientia enters AI drug discovery collaboration with Merck KGaA
September 20, 2023Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery
Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …
NICE shares draft guidance for AI’s use in radiotherapy treatment planning
August 14, 2023Research and Development AI, Draft Guidance, NICE, Oncology, radiotherapy
The National Institute for Health and Care Excellence (NICE) has shared draft guidance surrounding nine artificial intelligence (AI) technologies which …
Recursion and NVIDIA partner for AI-enabled drug discovery developments
July 13, 2023Research and Development AI, Pharmacy, Recursion, drug discovery
Clinical stage biotech company Recursion has announced a $50m investment by NVIDIA, intended to accelerate the development of its AI …
Anavex Life Sciences and Partex NV Group announce AI-based strategic partnership to enhance patient experience
June 28, 2023Research and Development AI, Anavex Life Sciences, Partex NV Group, Pharmacy, patient experience
US-based clinical-stage biopharmaceutical company Anavex Life Sciences and German digital pharma platform Partex NV Group have announced a strategic partnership …
Scientists use AI to find new antibiotic to fight superbug
May 26, 2023Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance
Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …
Personalised medicine in oncology: Where are we now?
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery
The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Exscientia to collaborate with EQRx on drug development
June 25, 2021Medical Communications AI, Exscientia, clinical drug development
Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …
Novartis announce digital collaboration with HPE
June 24, 2021AI, HPE, Novartis
Swiss pharma company, Novartis, has announced a collaboration with Hewlett Packard Enterprise (HPE), to accelerate its use of data and …
UK AI firm wins share of £140 million funding for lung cancer detection tech
June 18, 2021Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology
Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
